PTEN and breast neoplasm: This study highlights the importance of PI3Kβ in immune evasion in breast tumor, particularly in the context of PTEN loss, and suggests that pharmacological inhibition of PI3Kβ could enhance anticancer immunity when combined with immunotherapy.